GILD vs REGN
Gilead Sciences vs Regeneron Pharmaceuticals — AI-powered side-by-side comparison
| Metric | GILD | REGN |
|---|---|---|
| AI Score | 66 | 65 |
| Price | $129.81 | $664.56 |
| P/E Ratio | 18.11× | 15.80× |
| ROE | 42.2% | 14.3% |
| Revenue Growth YoY | 3.5% | 5.9% |
| Gross Margin | 79.3% | 85.7% |
| Debt / Equity | 1.10× | 0.09× |
| Dividend Yield | 2.4% | 0.6% |
| RSI (14) | 49.2 | 65.3 |
| Beta | 0.3411 | 0.2076 |
| Expected Upside | +21.1% | +12.5% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
GILD Full Analysis
REGN Full Analysis